The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade
- PMID: 1974718
- PMCID: PMC54470
- DOI: 10.1073/pnas.87.16.6054
The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade
Abstract
The protein product of the neu protooncogene, p185, is a tyrosine kinase with a high degree of sequence homology to the epidermal growth factor (EGF) receptor. Although p185 does not bind EGF, EGF stimulates tyrosine phosphorylation of p185. To determine the mechanism of this interaction we have used a vaccinia virus/bacteriophage T7-based transient gene expression system to induce production of normal and kinase-deficient forms of p185 in the absence and presence of EGF receptors. Tyrosine phosphorylation of kinase-deficient p185 was observed, but only in the presence of the EGF receptor. These findings strongly support the hypothesis that p185 is a substrate for the EGF receptor tyrosine kinase in a tyrosine kinase cascade.
Similar articles
-
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.Mol Cell Biol. 1986 May;6(5):1729-40. doi: 10.1128/mcb.6.5.1729-1740.1986. Mol Cell Biol. 1986. PMID: 2878363 Free PMC article.
-
EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.EMBO J. 1988 Apr;7(4):995-1001. doi: 10.1002/j.1460-2075.1988.tb02906.x. EMBO J. 1988. PMID: 3261240 Free PMC article.
-
Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93. doi: 10.1073/pnas.85.15.5389. Proc Natl Acad Sci U S A. 1988. PMID: 2899889 Free PMC article.
-
A chimeric EGFR/neu receptor in studies of neu function.Cancer Treat Res. 1992;61:213-28. doi: 10.1007/978-1-4615-3500-3_11. Cancer Treat Res. 1992. PMID: 1360234 Review. No abstract available.
-
Epidermal growth factor and its receptor.Mol Cell Endocrinol. 1987 Jun;51(3):169-86. doi: 10.1016/0303-7207(87)90027-x. Mol Cell Endocrinol. 1987. PMID: 3109978 Review.
Cited by
-
The neu-protein and breast cancer.Virchows Arch. 1995;426(2):107-15. doi: 10.1007/BF00192631. Virchows Arch. 1995. PMID: 7757280 Review.
-
Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.Br J Cancer. 1996 Nov;74(9):1427-33. doi: 10.1038/bjc.1996.560. Br J Cancer. 1996. PMID: 8912540 Free PMC article.
-
Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1500-4. doi: 10.1073/pnas.91.4.1500. Proc Natl Acad Sci U S A. 1994. PMID: 7509075 Free PMC article.
-
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.EMBO J. 1996 May 15;15(10):2452-67. EMBO J. 1996. PMID: 8665853 Free PMC article.
-
Tyrosine kinase activity may be necessary but is not sufficient for c-erbB1-mediated tissue-specific tumorigenicity.J Virol. 1994 Oct;68(10):6804-10. doi: 10.1128/JVI.68.10.6804-6810.1994. J Virol. 1994. PMID: 7916062 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous